Global Vortioxetine Market Growth 2020-2025

世界のボルチオキセチン市場予測2020-2025:5mg錠、10mg錠、15mg錠、20mg錠

◆タイトル:Global Vortioxetine Market Growth 2020-2025
◆商品コード:LPI20JN08375
◆調査・発行会社:LP Information
◆発行日:2020年6月
◆ページ数:138
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥402,600見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥603,900見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥805,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Informationの日本における正規販売代理店です。

【レポートの概要】

「ボルチオキセチンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、5mg錠、10mg錠、15mg錠、20mg錠など、用途別には、うつ病、全般性不安障害、注意欠陥多動性障害、その他などに区分してまとめた調査レポートです。ボルチオキセチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・ボルチオキセチンの世界市場概要(サマリー)
・ボルチオキセチンの企業別販売量・売上
・ボルチオキセチンの企業別市場シェア
・ボルチオキセチンの世界市場規模 2015年-2020年:種類別(5mg錠、10mg錠、15mg錠、20mg錠)
・ボルチオキセチンの世界市場規模 2015年-2020年:用途別(うつ病、全般性不安障害、注意欠陥多動性障害、その他)
・ボルチオキセチンの米州市場規模(アメリカ、カナダ、メキシコなど)
・ボルチオキセチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ボルチオキセチンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ボルチオキセチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ボルチオキセチン市場の成長要因・課題・動向
・ボルチオキセチンの世界市場予測 2021年-2025年
・ボルチオキセチンの米州市場予測(アメリカ、カナダ、メキシコなど)
・ボルチオキセチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ボルチオキセチンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ボルチオキセチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ボルチオキセチンの世界市場予測:種類別(5mg錠、10mg錠、15mg錠、20mg錠)
・ボルチオキセチンの世界市場予測:用途別(うつ病、全般性不安障害、注意欠陥多動性障害、その他)
・主要企業分析

According to this study, over the next five years the Vortioxetine market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vortioxetine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Vortioxetine market by type, application, key manufacturers and key regions and countries.

This study considers the Vortioxetine value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
5 Mg Tablets
10 Mg Tablet
15 Mg Tablet
20 Mg Tablet

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Depression
Generalized Anxiety Disorder
Attention Deficit Hyperactivity Disorder
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Takeda
Lundbeck
CGeneTech

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Vortioxetine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Vortioxetine market by identifying its various subsegments.
Focuses on the key global Vortioxetine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vortioxetine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vortioxetine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vortioxetine Consumption 2015-2025
2.1.2 Vortioxetine Consumption CAGR by Region
2.2 Vortioxetine Segment by Type
2.2.1 5 Mg Tablets
2.2.2 10 Mg Tablet
2.2.3 15 Mg Tablet
2.2.4 20 Mg Tablet
2.3 Vortioxetine Consumption by Type
2.3.1 Global Vortioxetine Consumption Market Share by Type (2015-2020)
2.3.2 Global Vortioxetine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vortioxetine Sale Price by Type (2015-2020)
2.4 Vortioxetine Segment by Application
2.4.1 Depression
2.4.2 Generalized Anxiety Disorder
2.4.3 Attention Deficit Hyperactivity Disorder
2.4.4 Other
2.5 Vortioxetine Consumption by Application
2.5.1 Global Vortioxetine Consumption Market Share by Type (2015-2020)
2.5.2 Global Vortioxetine Value and Market Share by Type (2015-2020)
2.5.3 Global Vortioxetine Sale Price by Type (2015-2020)

3 Global Vortioxetine by Company
3.1 Global Vortioxetine Sales Market Share by Company
3.1.1 Global Vortioxetine Sales by Company (2018-2020)
3.1.2 Global Vortioxetine Sales Market Share by Company (2018-2020)
3.2 Global Vortioxetine Revenue Market Share by Company
3.2.1 Global Vortioxetine Revenue by Company (2018-2020)
3.2.2 Global Vortioxetine Revenue Market Share by Company (2018-2020)
3.3 Global Vortioxetine Sale Price by Company
3.4 Global Vortioxetine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vortioxetine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vortioxetine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Vortioxetine by Regions
4.1 Vortioxetine by Regions
4.2 Americas Vortioxetine Consumption Growth
4.3 APAC Vortioxetine Consumption Growth
4.4 Europe Vortioxetine Consumption Growth
4.5 Middle East & Africa Vortioxetine Consumption Growth

5 Americas
5.1 Americas Vortioxetine Consumption by Countries
5.1.1 Americas Vortioxetine Consumption by Countries (2015-2020)
5.1.2 Americas Vortioxetine Value by Countries (2015-2020)
5.2 Americas Vortioxetine Consumption by Type
5.3 Americas Vortioxetine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Vortioxetine Consumption by Regions
6.1.1 APAC Vortioxetine Consumption by Regions (2015-2020)
6.1.2 APAC Vortioxetine Value by Regions (2015-2020)
6.2 APAC Vortioxetine Consumption by Type
6.3 APAC Vortioxetine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Vortioxetine by Countries
7.1.1 Europe Vortioxetine Consumption by Countries (2015-2020)
7.1.2 Europe Vortioxetine Value by Countries (2015-2020)
7.2 Europe Vortioxetine Consumption by Type
7.3 Europe Vortioxetine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Vortioxetine by Countries
8.1.1 Middle East & Africa Vortioxetine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vortioxetine Value by Countries (2015-2020)
8.2 Middle East & Africa Vortioxetine Consumption by Type
8.3 Middle East & Africa Vortioxetine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vortioxetine Distributors
10.3 Vortioxetine Customer

11 Global Vortioxetine Market Forecast
11.1 Global Vortioxetine Consumption Forecast (2021-2025)
11.2 Global Vortioxetine Forecast by Regions
11.2.1 Global Vortioxetine Forecast by Regions (2021-2025)
11.2.2 Global Vortioxetine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vortioxetine Forecast by Type
11.8 Global Vortioxetine Forecast by Application

12 Key Players Analysis
12.1 Takeda
12.1.1 Company Information
12.1.2 Vortioxetine Product Offered
12.1.3 Takeda Vortioxetine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Takeda Latest Developments
12.2 Lundbeck
12.2.1 Company Information
12.2.2 Vortioxetine Product Offered
12.2.3 Lundbeck Vortioxetine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Lundbeck Latest Developments
12.3 CGeneTech
12.3.1 Company Information
12.3.2 Vortioxetine Product Offered
12.3.3 CGeneTech Vortioxetine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CGeneTech Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Vortioxetine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 5 Mg Tablets
Table 5. Major Players of 10 Mg Tablet
Table 6. Major Players of 15 Mg Tablet
Table 7. Major Players of 20 Mg Tablet
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Vortioxetine Consumption Market Share by Type (2015-2020)
Table 10. Global Vortioxetine Revenue by Type (2015-2020) ($ million)
Table 11. Global Vortioxetine Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Vortioxetine Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Vortioxetine Consumption Market Share by Application (2015-2020)
Table 15. Global Vortioxetine Value by Application (2015-2020)
Table 16. Global Vortioxetine Value Market Share by Application (2015-2020)
Table 17. Global Vortioxetine Sale Price by Application (2015-2020)
Table 18. Global Vortioxetine Sales by Company (2017-2019) (M Pcs)
Table 19. Global Vortioxetine Sales Market Share by Company (2017-2019)
Table 20. Global Vortioxetine Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Vortioxetine Revenue Market Share by Company (2017-2019)
Table 22. Global Vortioxetine Sale Price by Company (2017-2019)
Table 23. Global Vortioxetine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Vortioxetine Products Offered
Table 25. Vortioxetine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Vortioxetine Consumption by Regions 2015-2020 (M Pcs)
Table 27. Global Vortioxetine Consumption Market Share by Regions 2015-2020
Table 28. Global Vortioxetine Value by Regions 2015-2020 ($ Millions)
Table 29. Global Vortioxetine Value Market Share by Regions 2015-2020
Table 30. Americas Vortioxetine Consumption by Countries (2015-2020) (M Pcs)
Table 31. Americas Vortioxetine Consumption Market Share by Countries (2015-2020)
Table 32. Americas Vortioxetine Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Vortioxetine Value Market Share by Countries (2015-2020)
Table 34. Americas Vortioxetine Consumption by Type (2015-2020) (M Pcs)
Table 35. Americas Vortioxetine Consumption Market Share by Type (2015-2020)
Table 36. Americas Vortioxetine Consumption by Application (2015-2020) (M Pcs)
Table 37. Americas Vortioxetine Consumption Market Share by Application (2015-2020)
Table 38. APAC Vortioxetine Consumption by Countries (2015-2020) (M Pcs)
Table 39. APAC Vortioxetine Consumption Market Share by Countries (2015-2020)
Table 40. APAC Vortioxetine Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Vortioxetine Value Market Share by Regions (2015-2020)
Table 42. APAC Vortioxetine Consumption by Type (2015-2020) (M Pcs)
Table 43. APAC Vortioxetine Consumption Market Share by Type (2015-2020)
Table 44. APAC Vortioxetine Consumption by Application (2015-2020) (M Pcs)
Table 45. APAC Vortioxetine Consumption Market Share by Application (2015-2020)
Table 46. Europe Vortioxetine Consumption by Countries (2015-2020) (M Pcs)
Table 47. Europe Vortioxetine Consumption Market Share by Countries (2015-2020)
Table 48. Europe Vortioxetine Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Vortioxetine Value Market Share by Countries (2015-2020)
Table 50. Europe Vortioxetine Consumption by Type (2015-2020) (M Pcs)
Table 51. Europe Vortioxetine Consumption Market Share by Type (2015-2020)
Table 52. Europe Vortioxetine Consumption by Application (2015-2020) (M Pcs)
Table 53. Europe Vortioxetine Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Vortioxetine Consumption by Countries (2015-2020) (M Pcs)
Table 55. Middle East & Africa Vortioxetine Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Vortioxetine Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Vortioxetine Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Vortioxetine Consumption by Type (2015-2020) (M Pcs)
Table 59. Middle East & Africa Vortioxetine Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Vortioxetine Consumption by Application (2015-2020) (M Pcs)
Table 61. Middle East & Africa Vortioxetine Consumption Market Share by Application (2015-2020)
Table 62. Vortioxetine Distributors List
Table 63. Vortioxetine Customer List
Table 64. Global Vortioxetine Consumption Forecast by Countries (2021-2025) (M Pcs)
Table 65. Global Vortioxetine Consumption Market Forecast by Regions
Table 66. Global Vortioxetine Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Vortioxetine Value Market Share Forecast by Regions
Table 68. Global Vortioxetine Consumption Forecast by Type (2021-2025) (M Pcs)
Table 69. Global Vortioxetine Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Vortioxetine Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Vortioxetine Value Market Share Forecast by Type (2021-2025)
Table 72. Global Vortioxetine Consumption Forecast by Application (2021-2025) (M Pcs)
Table 73. Global Vortioxetine Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Vortioxetine Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Vortioxetine Value Market Share Forecast by Application (2021-2025)
Table 76. Takeda Product Offered
Table 77. Takeda Vortioxetine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 78. Takeda Main Business
Table 79. Takeda Latest Developments
Table 80. Takeda Basic Information, Company Total Revenue (in $ million), Vortioxetine Manufacturing Base, Sales Area and Its Competitors
Table 81. Lundbeck Product Offered
Table 82. Lundbeck Vortioxetine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 83. Lundbeck Main Business
Table 84. Lundbeck Latest Developments
Table 85. Lundbeck Basic Information, Company Total Revenue (in $ million), Vortioxetine Manufacturing Base, Sales Area and Its Competitors
Table 86. CGeneTech Product Offered
Table 87. CGeneTech Vortioxetine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 88. CGeneTech Main Business
Table 89. CGeneTech Latest Developments
Table 90. CGeneTech Basic Information, Company Total Revenue (in $ million), Vortioxetine Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Vortioxetine
Figure 2. Vortioxetine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Vortioxetine Consumption Growth Rate 2015-2025 (M Pcs)
Figure 5. Global Vortioxetine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 5 Mg Tablets
Figure 7. Product Picture of 10 Mg Tablet
Figure 8. Product Picture of 15 Mg Tablet
Figure 9. Product Picture of 20 Mg Tablet
Figure 10. Global Vortioxetine Consumption Market Share by Type (2015-2020)
Figure 11. Global Vortioxetine Value Market Share by Type (2015-2020)
Figure 12. Vortioxetine Consumed in Depression
Figure 13. Global Vortioxetine Market: Depression (2015-2020) (M Pcs)
Figure 14. Global Vortioxetine Market: Depression (2015-2020) ($ Millions)
Figure 15. Vortioxetine Consumed in Generalized Anxiety Disorder
Figure 16. Global Vortioxetine Market: Generalized Anxiety Disorder (2015-2020) (M Pcs)
Figure 17. Global Vortioxetine Market: Generalized Anxiety Disorder (2015-2020) ($ Millions)
Figure 18. Vortioxetine Consumed in Attention Deficit Hyperactivity Disorder
Figure 19. Global Vortioxetine Market: Attention Deficit Hyperactivity Disorder (2015-2020) (M Pcs)
Figure 20. Global Vortioxetine Market: Attention Deficit Hyperactivity Disorder (2015-2020) ($ Millions)
Figure 21. Vortioxetine Consumed in Other
Figure 22. Global Vortioxetine Market: Other (2015-2020) (M Pcs)
Figure 23. Global Vortioxetine Market: Other (2015-2020) ($ Millions)
Figure 24. Global Vortioxetine Consumption Market Share by Application (2015-2020)
Figure 25. Global Vortioxetine Value Market Share by Application (2015-2020)
Figure 26. Global Vortioxetine Sales Market Share by Company in 2017
Figure 27. Global Vortioxetine Sales Market Share by Company in 2019
Figure 28. Global Vortioxetine Revenue Market Share by Company in 2017
Figure 29. Global Vortioxetine Revenue Market Share by Company in 2019
Figure 30. Global Vortioxetine Sale Price by Company in 2019
Figure 31. Global Vortioxetine Consumption Market Share by Regions 2015-2020
Figure 32. Global Vortioxetine Value Market Share by Regions 2015-2020
Figure 33. Americas Vortioxetine Consumption 2015-2020 (M Pcs)
Figure 34. Americas Vortioxetine Value 2015-2020 ($ Millions)
Figure 35. APAC Vortioxetine Consumption 2015-2020 (M Pcs)
Figure 36. APAC Vortioxetine Value 2015-2020 ($ Millions)
Figure 37. Europe Vortioxetine Consumption 2015-2020 (M Pcs)
Figure 38. Europe Vortioxetine Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Vortioxetine Consumption 2015-2020 (M Pcs)
Figure 40. Middle East & Africa Vortioxetine Value 2015-2020 ($ Millions)
Figure 41. Americas Vortioxetine Consumption Market Share by Countries in 2019
Figure 42. Americas Vortioxetine Value Market Share by Countries in 2019
Figure 43. Americas Vortioxetine Consumption Market Share by Type in 2019
Figure 44. Americas Vortioxetine Consumption Market Share by Application in 2019
Figure 45. United States Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 46. United States Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 48. Canada Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 50. Mexico Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Vortioxetine Consumption Market Share by Countries in 2019
Figure 52. APAC Vortioxetine Value Market Share by Regions in 2019
Figure 53. APAC Vortioxetine Consumption Market Share by Type in 2019
Figure 54. APAC Vortioxetine Consumption Market Share by Application in 2019
Figure 55. China Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 56. China Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 58. Japan Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 60. Korea Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 62. Southeast Asia Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 63. India Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 64. India Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 66. Australia Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Vortioxetine Consumption Market Share by Countries in 2019
Figure 68. Europe Vortioxetine Value Market Share by Countries in 2019
Figure 69. Europe Vortioxetine Consumption Market Share by Type in 2019
Figure 70. Europe Vortioxetine Consumption Market Share by Application in 2019
Figure 71. Germany Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 72. Germany Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 73. France Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 74. France Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 75. UK Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 76. UK Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 78. Italy Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 80. Russia Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Vortioxetine Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Vortioxetine Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Vortioxetine Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Vortioxetine Consumption Market Share by Application in 2019
Figure 85. Egypt Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 86. Egypt Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 88. South Africa Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 90. Israel Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 92. Turkey Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Vortioxetine Consumption Growth 2015-2020 (M Pcs)
Figure 94. GCC Countries Vortioxetine Value Growth 2015-2020 ($ Millions)
Figure 95. Global Vortioxetine Consumption Growth Rate Forecast (2021-2025) (M Pcs)
Figure 96. Global Vortioxetine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 98. Americas Vortioxetine Value 2021-2025 ($ Millions)
Figure 99. APAC Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 100. APAC Vortioxetine Value 2021-2025 ($ Millions)
Figure 101. Europe Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 102. Europe Vortioxetine Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 104. Middle East & Africa Vortioxetine Value 2021-2025 ($ Millions)
Figure 105. United States Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 106. United States Vortioxetine Value 2021-2025 ($ Millions)
Figure 107. Canada Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 108. Canada Vortioxetine Value 2021-2025 ($ Millions)
Figure 109. Mexico Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 110. Mexico Vortioxetine Value 2021-2025 ($ Millions)
Figure 111. Brazil Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 112. Brazil Vortioxetine Value 2021-2025 ($ Millions)
Figure 113. China Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 114. China Vortioxetine Value 2021-2025 ($ Millions)
Figure 115. Japan Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 116. Japan Vortioxetine Value 2021-2025 ($ Millions)
Figure 117. Korea Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 118. Korea Vortioxetine Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 120. Southeast Asia Vortioxetine Value 2021-2025 ($ Millions)
Figure 121. India Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 122. India Vortioxetine Value 2021-2025 ($ Millions)
Figure 123. Australia Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 124. Australia Vortioxetine Value 2021-2025 ($ Millions)
Figure 125. Germany Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 126. Germany Vortioxetine Value 2021-2025 ($ Millions)
Figure 127. France Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 128. France Vortioxetine Value 2021-2025 ($ Millions)
Figure 129. UK Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 130. UK Vortioxetine Value 2021-2025 ($ Millions)
Figure 131. Italy Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 132. Italy Vortioxetine Value 2021-2025 ($ Millions)
Figure 133. Russia Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 134. Russia Vortioxetine Value 2021-2025 ($ Millions)
Figure 135. Spain Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 136. Spain Vortioxetine Value 2021-2025 ($ Millions)
Figure 137. Egypt Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 138. Egypt Vortioxetine Value 2021-2025 ($ Millions)
Figure 139. South Africa Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 140. South Africa Vortioxetine Value 2021-2025 ($ Millions)
Figure 141. Israel Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 142. Israel Vortioxetine Value 2021-2025 ($ Millions)
Figure 143. Turkey Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 144. Turkey Vortioxetine Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Vortioxetine Consumption 2021-2025 (M Pcs)
Figure 146. GCC Countries Vortioxetine Value 2021-2025 ($ Millions)
Figure 147. Takeda Vortioxetine Market Share (2018-2020)
Figure 148. Lundbeck Vortioxetine Market Share (2018-2020)
Figure 149. CGeneTech Vortioxetine Market Share (2018-2020)


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のボルチオキセチン市場予測2020-2025:5mg錠、10mg錠、15mg錠、20mg錠] (Global Vortioxetine Market Growth 2020-2025 / LPI20JN08375)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆